ACCURAY INCORPORATED Restructuring and Related Cost, Expected Number of Positions Eliminated
ACCURAY INCORPORATED (ARAY) reported Restructuring and Related Cost, Expected Number of Positions Eliminated of 51 position for the 3-month period ending 2011-12-31, per its 10-K filed 2012-09-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated · last filed 2012-09-10
- ACCURAY INCORPORATED restructuring and related cost, expected number of positions eliminated for the quarter ending 2011-12-31 was 51.00 position.
| Period end | Restructuring and Related Cost, Expected Number of Positions Eliminated 3 month |
|---|---|
| 2011-12-31 | 51.00 position 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |